Megan D. Bailey will step down as executive vice president and president, Central Laboratories and International, effective Sept. 4, 2026.
Brian J. Caveney, M.D., will take the executive vice president and president, Biopharma Laboratory Services role on Sept. 1, 2026.
Caveney currently leads Early Development Research Laboratories as executive vice president and president, serving as chief medical and scientific officer.
Expanded remit includes oversight of Early Development Research Laboratories, Central Laboratories.